Pharmaceuticals news FT.com

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Pharma group builds out American supply chains as part of preparations for potential US tariffs

Apr 11, 2025 - 08:17
 0
Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D
Pharma group builds out American supply chains as part of preparations for potential US tariffs
Read More

Tags:

Previous Article

What is a Revenue Management System? The ultimate guide to RMS

Next Article

Stratasys Launches New SLA and PolyJet Solutions at RAPID + TCT 2025

Related Posts

Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump

Eli Lilly unveils $27bn US investment as corporate Amer...

Feb 26, 2025  0

Higher medicine sales tax makes UK ‘uninvestable’, warn drugmakers

Higher medicine sales tax makes UK ‘uninvestable’, warn...

Mar 20, 2025  0

Roche signs biggest-ever obesity drug deal

Roche signs biggest-ever obesity drug deal

Mar 12, 2025  0